Episode

Circulation August 11, 2026 Issue

Podcast
Circulation on the Run
Published
Aug 10, 2026
Duration seconds
1604
Processing state
not_requested
Canonical source
https://circulation.libsyn.com/circulation-august-11-2026-issue
Audio
https://dts.podtrac.com/redirect.mp3/traffic.libsyn.com/secure/circulation/COTR154_06_master.mp3?dest-id=376443
JSON
/v1/public/podcasts/circulation-on-the-run-1003485/episodes/circulation-august-11-2026-issue
Markdown
/podcast/circulation-on-the-run-1003485/circulation-august-11-2026-issue.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/circulation-on-the-run-1003485/episodes/circulation-august-11-2026-issue/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/circulation-on-the-run-1003485/circulation-august-11-2026-issue.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

This week, please join Brad and Mercedes as they welcome Deputy Editor Ryan J. Tedford and they discuss the advance of SGLT-2, non-steroidal MRA, and GLP-1 therapies that provide clinicians options to treat patients and HFpEF comorbidities. Then, Associate Editor Mark Chandy joins the podcast to discuss highlights from the recent BCVS Scientific Sessions in Boston, as well as how he prioritizes different types of basic and scientific manuscripts at Circulation . For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260810.584625